Vital KSK, 3 Other Firms Invest in LinDo to Drive Japan Launch of Innovative Drugs

February 19, 2024
Vital KSK Holdings said on February 14 that it has invested in LinDo, a Tokyo-based drug maker committed to bringing over novel medicines that are being developed in the US and Europe but not in Japan, together with Forest Holdings,...read more